Cronos Group Inc.

TSX:CRON.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$4.57 -0.27%

-$0.01 today

Market cap
$1.67B
Beta
1.25
P/E (TTM)
-488.1
EPS (TTM)
-$0.01
52W Low $2.54High $4.66

Volume 0.15M

Average 0.19M

CRON.TO Gross Profit

Revenue minus cost of revenue: what remains to cover operating expenses after paying for what was sold.

Cronos Group Inc.TSX: CRON.TO

Gross Profit · Q1 FY2026 · quarter ended Mar 2026

Gross profit grows, but more slowly than its trailing trend

Q1 FY2026 gross profit of $18.42M rose 38.8% year over year, behind the +71.5% change in trailing-twelve-month gross profit. Sequentially, it rose 14.9% from the prior quarter. Over 3 fiscal years it compounded at +58.2% a year.

Context

  • Gross profit amounted to 41.4% of revenue in FY2025, up 15.5 pp from a year earlier.
  • Gross profit increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +38.8% toward the trailing-twelve-month pace of +71.5%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$18.42M+14.9% QoQ
Last fiscal yearDec 2025
$61.7M+102.6% YoY
LTMMar 2026
$67.28M+71.5% YoY
Gross Profit past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+38.8%——
1 year+102.6%——
3-year CAGR+58.2%——
5-year CAGR——
10-year CAGR——

Gross Profit history

USD · from the income statement

Latest · FY2025
61.7M USD
Year-over-year change
+102.6%

Gross Profit vs competitors

How CRON.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so gross profit is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +71.5% is the highest of 6, against a peer median of +0.6%.
  • Gross profit amounts to 42.2% of revenue for CRON.TO, versus a peer median of 37.0%.
CRON.TO Competitors
Gross Profit for CRON.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
EXE.TOExtendicare Inc.LTM Jun 2026CA$781.2M CAD-32.8%+37.5%39.5%
WELL.TOWELL Health Technologies Corp.LTM Mar 2026CA$545.21M CAD+51.0%+20.1%37.0%
TLRY.TOTilray Brands, Inc.LTM Feb 2026$237.55M USD+0.6%+27.2%27.7%
GUD.TOKnight Therapeutics Inc.LTM Mar 2026CA$190.52M CAD+13.7%+3.0%37.3%
SIA.TOSienna Senior Living Inc.LTM Sep 2026CA$156.57M CAD-7.6%+0.5%14.1%
CRON.TOCronos Group Inc.LTM Mar 2026$67.28M USD+71.5%+58.2%42.2%
Peer median (excluding CRON.TO) —+0.6%+20.1%37.0%

Competitors are the stored peer set for CRON.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue64.02M87.54M87.03M117.5M149.15M
Cost of Revenue81.47M71.96M75.15M87.05M87.45M
Gross Profit(17.45M)15.58M11.88M30.45M61.7M
Gross Margin-27.3%17.8%13.7%25.9%41.4%
Research & Development21.66M13.25M5.83M4.22M4.53M
Selling, General & Admin120.67M101.64M80.74M76.74M75.01M
Operating Expenses272.09M128.01M96.48M106.91M79.54M
Depreciation & Amortization13.36M11.52M7.44M8.84M14.48M
EBITDA(150.79M)(93.81M)(72.28M)(45.37M)(2.94M)
EBITDA Margin-235.5%-107.2%-83.0%-38.6%-2.0%
Operating Income(289.54M)(112.44M)(84.6M)(76.46M)(17.84M)
Operating Margin-452.2%-128.4%-97.2%-65.1%-12.0%
Interest Income8.92M21.84M52.07M49.52M40.66M
Interest Expense00000
Other Income / Expenses162.1M(9.66M)11.1M113.01M419.21K
Income Before Tax(127.44M)(122.1M)(73.49M)36.55M(17.42M)
Pre-Tax Margin-199.1%-139.5%-84.4%31.1%-11.7%
Income Tax Expense(427.41K)34.48M(3.23M)(3.44M)(14.44M)
Net Income(392.81M)(170.26M)(73.79M)41.04M(9.61M)
Net Margin-613.5%-194.5%-84.8%34.9%-6.4%
EPS (Basic)(0.34)(0.42)(0.18)0.10(0.03)
EPS (Diluted)(0.34)(0.42)(0.18)0.10(0.03)
Weighted Avg Shares369.73M370.39M380.96M382.16M383.47M
Weighted Avg Shares (Diluted)370.39M370.39M380.96M382.16M383.47M

Cronos Group Inc.

TSX:CRON.TO

Intrinsic Alpha fair value

Locked

Current Price

$4.57

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.